Founded in 2018, Ark is a biotechnological company which specializes on early detection technology of tumors. They developes new-generation blood tests without invasive features on detecting early stage cancers. Besides, Ark is now collaborating with top medical research instituions globally on miRNA clinical studies.
| Company Name | Ark Bio |
|---|---|
| Brand Name | Ark Bio |
| Industries | BioTech Healthcare |
| Year of Establishment | 2018 |
| Founder(s) | Isaac Ho Zhou Lihan Zou Ruiyang |
| No. of Employees | / |
| Regional Coverage | Singapore |
| Clients | / |
| Stage | Seires A |
| Investor(s) | Venturecraft Group Gaorong Capital |
| Fundraising History | 40M USD (Nov 2018) |
| Raising Fund | / |
| Fundraising target | / |
| Pre-money valuation | / |
| Post-money Valuation | / |
| Media Exposure | / |
| Company Email | [email protected] |
[dcb id=160440]